Inactivating mutations in CDC73 were first discovered in hyperparathyroidism-jaw tumor syndrome (HPT-JT), an autosomal dominant genetic disease featuring parathyroid tumors with fibro-osseous jaw tumors as well as uterine and renal lesions [4]. Here, CDC73 is linked to tumor of parathyroid gland.